Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 7;19(3):e0299607.
doi: 10.1371/journal.pone.0299607. eCollection 2024.

Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves

Affiliations

Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves

Daniela Helena Machado Freitas et al. PLoS One. .

Abstract

Background: The emergence of SARS-CoV-2 variants led to subsequent waves of COVID-19 worldwide. In many countries, the second wave of COVID-19 was marked by record deaths, raising the concern that variants associated with that wave might be more deadly. Our aim was to compare outcomes of critically-ill patients of the first two waves of COVID-19.

Methods: This retrospective cohort included critically-ill patients admitted between March-June 2020 and April-July 2021 in the largest academic hospital in Brazil, which has free-access universal health care system. We compared admission characteristics and hospital outcomes. The main outcome was 60-day survival and we built multivariable Cox model based on a conceptual causal diagram in the format of directed acyclic graph (DAG).

Results: We included 1583 patients (1315 in the first and 268 in the second wave). Patients in the second wave were younger, had lower severity scores, used prone and non-invasive ventilatory support more often, and fewer patients required mechanical ventilation (70% vs 80%, p<0.001), vasopressors (60 vs 74%, p<0.001), and dialysis (22% vs 37%, p<0.001). Survival was higher in the second wave (HR 0.61, 95%CI 0.50-0.76). In the multivariable model, admission during the second wave, adjusted for age, SAPS3 and vaccination, was not associated with survival (aHR 0.85, 95%CI 0.65-1.12).

Conclusions: In this cohort study, patients with COVID-19 admitted to the ICU in the second wave were younger and had better prognostic scores. Adjusted survival was similar in the two waves, contrasting with record number of hospitalizations, daily deaths and health system collapse seen across the country in the second wave. Our findings suggest that the combination of the burden of severe cases and factors such as resource allocation and health disparities may have had an impact in the excess mortality found in many countries in the second wave.

PubMed Disclaimer

Conflict of interest statement

Dr. Ferreira reports personal fees from Medtronic, outside the submitted work; Dr. Costa reports personal fees from Timpel, personal fees from Magnamed, outside the submitted work; Dr. Ho reports personal fees from Pan‐American Health Organization, outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors have no conflict of interest to disclose.

Figures

Fig 1
Fig 1. Study participant flow chart.
Flow of potentially eligible participants in the study, and final numbers included and analyzed. ICU: Intensive Care Unit; COVID-19: Coronavirus Disease 2019.
Fig 2
Fig 2. Hospital 60-day survival according to year of admission.
Solid red line represents survival of patients who were admitted in 2020 (first wave) and solid blue line represents survival of patients who were admitted in 2021 (second wave). (A) Unadjusted survival, logrank p<0.001 and HR 0.61, 95%CI 0.50–0.76. (B) Survival adjusted by age, SAPS 3 and vacination (aHR 0.85, 95%CI 0.65–1.12). The p values were obtained with Cox proportional hazards models.

References

    1. World Health Organization (WHO). Coronavirus Disease (COVID-19) Dashboard. Geneva: WHO; 2023. Available from: https://covid19.who.int/. Accessed 2023 July 7.
    1. Ferreira JC, Ho YL, Besen BAMP, Malbouisson LMS, Taniguchi LU, Mendes PV, et al.. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021. Jun 7;11(1):92. doi: 10.1186/s13613-021-00882-w - DOI - PMC - PubMed
    1. Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baião F, Hamacher S, et al.. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021. Apr 1;9(4):407–418. doi: 10.1016/S2213-2600(20)30560-9 - DOI - PMC - PubMed
    1. World Health Organization (WHO). Tracking SARS-CoV-2 variants. Geneva: WHO; 2023. Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants. Accessed 2022 Oct 24.
    1. Gräf T, Bello G, Naveca FG, Gomes M, Cardoso VLO, da Silva AF, et al.. Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil. iScience. 2022. Apr 15;25(4):104156. doi: 10.1016/j.isci.2022.104156 - DOI - PMC - PubMed

Supplementary concepts

LinkOut - more resources